TXN Options Shift Defensive as Q3 Report Looms

Texas Instruments heads into its Q3 print on October 21 with options positioning noticeably more cautious than when an earlier preview was published just days ago.

The clearest change since the October 17 article is in the options market. The put/call ratio has climbed to 0.81, now running about 1.4 standard deviations above its 20-day average of 0.78. That is a meaningful shift from the near-zero z-score noted earlier in the week, pointing to a pickup in demand for downside protection in the final sessions before the release. The stock itself has been quiet, down roughly 2% on the week to $276.15, broadly in line with peers: ADI fell 2.6% on the week, MCHP dropped 2.3%, and ON declined 7.1%, so TXN is holding up better than some of its analog and embedded processing rivals. The borrow market remains irrelevant as a signal. Short interest at 2.2% of the free float is low, availability is essentially uncapped, and cost to borrow at 0.41% is trivial despite a 22% week-on-week uptick from a very low base.

The fundamental debate has not changed materially since last quarter's results. Bulls argue that Q2's 23% revenue growth to $5.46 billion, 61.4% gross margins, and 52% year-on-year EPS growth to $2.14 reflect durable end-market recovery across industrial, automotive, and data center rather than a temporary restocking bounce. TXN's roughly 30-week lead times versus competitors near 52 weeks are cited as a structural advantage that supports both supply reliability and pricing power. Bears counter that market share erosion in analog and embedded businesses, which together generate around 90% of revenue, is the more important signal, and that the stock's initial weakness after the Q2 release suggests the Street remains unconvinced that improving backlog and factory loadings translate into sustained earnings growth. Morgan Stanley holds an Underweight with a $255 target, sitting well below the current price, while the consensus mean target of $324 implies meaningful upside from here. Goldman Sachs carries a Sell at $225. Most other firms that moved after Q2 raised targets while holding existing ratings, a pattern that reflects recognition of the recovery without a conviction upgrade.

Retail attention has picked up heading into the print. Wikipedia page views for TXN are running about 1.9 standard deviations above the stock's own 90-day baseline, according to data from the Wikimedia Foundation tracked by ORTEX. That is an attention signal, not a revenue or demand indicator, but it does confirm that the release is drawing broader interest than usual.

The Q3 print is therefore less a test of whether Texas Instruments is recovering and more a test of whether the pace of that recovery, and the margin trajectory that comes with it, can satisfy a market that already sold the stock after a strong Q2 beat.